• Education
    • Higher Education
    • Scholarships & Grants
    • Online Learning
    • School Reforms
    • Research & Innovation
  • Lifestyle
    • Travel
    • Food & Drink
    • Fashion & Beauty
    • Home & Living
    • Relationships & Family
  • Technology & Startups
    • Software & Apps
    • Startup Success Stories
    • Startups & Innovations
    • Tech Regulations
    • Venture Capital
    • Artificial Intelligence
    • Cybersecurity
    • Emerging Technologies
    • Gadgets & Devices
    • Industry Analysis
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy
Today Headline
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
  • Home
  • World News
    • Us & Canada
    • Europe
    • Asia
    • Africa
    • Middle East
  • Politics
    • Elections
    • Political Parties
    • Government Policies
    • International Relations
    • Legislative News
  • Business & Finance
    • Market Trends
    • Stock Market
    • Entrepreneurship
    • Corporate News
    • Economic Policies
  • Science & Environment
    • Space Exploration
    • Climate Change
    • Wildlife & Conservation
    • Environmental Policies
    • Medical Research
  • Health
    • Public Health
    • Mental Health
    • Medical Breakthroughs
    • Fitness & Nutrition
    • Pandemic Updates
  • Sports
    • Football
    • Basketball
    • Tennis
    • Olympics
    • Motorsport
  • Entertainment
    • Movies
    • Music
    • TV & Streaming
    • Celebrity News
    • Awards & Festivals
  • Crime & Justice
    • Court Cases
    • Cybercrime
    • Policing
    • Criminal Investigations
    • Legal Reforms
No Result
View All Result
Today Headline
No Result
View All Result
Home Technology & Startups

Regeneron beats quarterly estimates on eczema drug demand; launches dividend program

February 4, 2025
in Technology & Startups
Reading Time: 2 mins read
A A
0
5
SHARES
10
VIEWS
Share on FacebookShare on Twitter


(Reuters) – Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program, sending its shares up 2.2% premarket.

U.S. sales of Eylea, which has been its long-standing cash cow, rose by 2% to $1.5 billion, including $305 million from the higher 8-milligram dose version.

Analysts were expecting $1.77 billion in total Eylea sales, according to LSEG data.

Regeneron, which developed Eylea in collaboration with Bayer AG, seeks to upgrade the eye medication users to a high-dose version as the drug faces threats from biosimilars and rivals, including Swiss drugmaker Roche’s Vabysmo.

Roche said last week it expects its adjusted per-share profit to increase at a high single-digit percentage this year, banking on strong demand for Vabysmo.

Regeneron said last month that overall Eylea sales benefitted by about $85 million from higher wholesaler inventory levels. However, the higher dose was negatively impacted by lower inventory levels and a lower net selling price compared to a year ago.

The Tarrytown, New York-based drugmaker’s board also approved the initiation of a cash dividend program, which will continue on a quarterly basis, with 88 cents per share payable to shareholders on March 20.

It also announced an additional $3 billion share repurchase program, bringing total current capacity to around $4.5 billion.

Regeneron’s total revenue of $3.79 billion beat analysts’ expectations of $3.75 billion, as per LSEG-compiled data.

Sales of anti-inflammatory drug Dupixent rose 15% to $3.7 billion. The French partner, Sanofi, records Dupixent’s sales and the profits are split equally between the companies.

Its skin cancer drug, Libtayo, brought in sales of $366.9 million, above estimates of $333.5 million. Regeneron bought the global rights to the cancer drug from partner Sanofi in 2022.

The company reported an adjusted profit of $12.07 per share in the quarter, above analysts’ average estimate of $11.28.

(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)

Tags: eczema treatmentLSEGprofit estimatesRegeneron Pharmaceuticals
Previous Post

N.Y. moves to shield abortion medication prescriptions after Louisiana indicts doctor

Next Post

South Korea to rebuild aviation safety system ‘from the ground up’ after crash, plane fire

Related Posts

Dutch car sharing firm adds Renault EVs capable of powering local grid

June 4, 2025
3

Nvidia dethrones Microsoft as the world’s most valuable publicly traded company with a $3.45 trillion market cap

June 4, 2025
5
Next Post
Download app from appStore

South Korea to rebuild aviation safety system 'from the ground up' after crash, plane fire

  • Trending
  • Comments
  • Latest
Family calls for change after B.C. nurse dies by suicide after attacks on the job

Family calls for change after B.C. nurse dies by suicide after attacks on the job

April 2, 2025
Pioneering 3D printing project shares successes

Product reduces TPH levels to non-hazardous status

November 27, 2024

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

December 31, 2024

Police ID man who died after Corso Italia fight

December 23, 2024
Harris tells supporters 'never give up' and urges peaceful transfer of power

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

0
Des Moines Man Accused Of Shooting Ex-Girlfriend's Mother

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

0

Trump ‘looks forward’ to White House meeting with Biden

0
Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

0
Israeli forces kill 27 in second Gaza aid massacre in three days

Israeli forces kill 27 in second Gaza aid massacre in three days

June 4, 2025

Ghana extends oil licenses with Tullow and partners to 2040 todayheadline

June 4, 2025

New SriLankan Board “stalled” buying of 2 wide body aircrafts over fitness concerns todayheadline

June 4, 2025
Future generations thinking can change minds about the world we want to live in – Inside track

Future generations thinking can change minds about the world we want to live in – Inside track

June 4, 2025

Recent News

Israeli forces kill 27 in second Gaza aid massacre in three days

Israeli forces kill 27 in second Gaza aid massacre in three days

June 4, 2025
3

Ghana extends oil licenses with Tullow and partners to 2040 todayheadline

June 4, 2025
4

New SriLankan Board “stalled” buying of 2 wide body aircrafts over fitness concerns todayheadline

June 4, 2025
3
Future generations thinking can change minds about the world we want to live in – Inside track

Future generations thinking can change minds about the world we want to live in – Inside track

June 4, 2025
4

TodayHeadline is a dynamic news website dedicated to delivering up-to-date and comprehensive news coverage from around the globe.

Follow Us

Browse by Category

  • Africa
  • Asia
  • Basketball
  • Business & Finance
  • Climate Change
  • Crime & Justice
  • Cybersecurity
  • Economic Policies
  • Elections
  • Entertainment
  • Entrepreneurship
  • Environmental Policies
  • Europe
  • Football
  • Gadgets & Devices
  • Health
  • Medical Research
  • Mental Health
  • Middle East
  • Motorsport
  • Olympics
  • Politics
  • Public Health
  • Relationships & Family
  • Science & Environment
  • Software & Apps
  • Space Exploration
  • Sports
  • Stock Market
  • Technology & Startups
  • Tennis
  • Travel
  • Uncategorized
  • Us & Canada
  • Wildlife & Conservation
  • World News

Recent News

Israeli forces kill 27 in second Gaza aid massacre in three days

Israeli forces kill 27 in second Gaza aid massacre in three days

June 4, 2025

Ghana extends oil licenses with Tullow and partners to 2040 todayheadline

June 4, 2025
  • Education
  • Lifestyle
  • Technology & Startups
  • About us
  • Contact
  • Advertise with Us
  • Privacy & Policy

© 2024 Todayheadline.co

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Business & Finance
  • Corporate News
  • Economic Policies
  • Entrepreneurship
  • Market Trends
  • Crime & Justice
  • Court Cases
  • Criminal Investigations
  • Cybercrime
  • Legal Reforms
  • Policing
  • Education
  • Higher Education
  • Online Learning
  • Entertainment
  • Awards & Festivals
  • Celebrity News
  • Movies
  • Music
  • Health
  • Fitness & Nutrition
  • Medical Breakthroughs
  • Mental Health
  • Pandemic Updates
  • Lifestyle
  • Fashion & Beauty
  • Food & Drink
  • Home & Living
  • Politics
  • Elections
  • Government Policies
  • International Relations
  • Legislative News
  • Political Parties
  • Africa
  • Asia
  • Europe
  • Middle East
  • Artificial Intelligence
  • Cybersecurity
  • Emerging Technologies
  • Gadgets & Devices
  • Industry Analysis
  • Basketball
  • Football
  • Motorsport
  • Olympics
  • Climate Change
  • Environmental Policies
  • Medical Research
  • Science & Environment
  • Space Exploration
  • Wildlife & Conservation
  • Sports
  • Tennis
  • Technology & Startups
  • Software & Apps
  • Startup Success Stories
  • Startups & Innovations
  • Tech Regulations
  • Venture Capital
  • Uncategorized
  • World News
  • Us & Canada
  • Public Health
  • Relationships & Family
  • Travel
  • Research & Innovation
  • Scholarships & Grants
  • School Reforms
  • Stock Market
  • TV & Streaming
  • Advertise with Us
  • Privacy & Policy
  • About us
  • Contact

© 2024 Todayheadline.co